Catalyst Wire Dossier Catalyst Wire Dossier

Sebetralstat

Sebetralstat · KalVista Pharmaceuticals, Ltd.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Sebetralstat, covering 2025-08-06 to 2026-02-04. Get the full timeline:

Most recent: Clinical Trial Update: Treatment of Angioedema Attacks in Pediatric (Ages 2-11) Post-Trial and Naive Patients With HAE With Sebetralstat

See pricing